Caliway Biopharmaceuticals Co (TPE:6919) Institutional Ownership: 8.91% (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6919 Caliway Biopharmaceuticals Co Ltd TPE:6919
55 GF Score
Price NT$99.60
GF Value NT$59.00
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Caliway Biopharmaceuticals Co Institutional Ownership?

Caliway Biopharmaceuticals Co TPE:6919 -3.30% 55 Institutional Ownership is 8.91% as of Aug. 31, 2026. GuruFocus rates TPE:6919 with a GF Score™ of 55/100 and a GF Value™ of NT$59.00 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Caliway Biopharmaceuticals Co's institutional ownership is 8.91%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Caliway Biopharmaceuticals Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Caliway Biopharmaceuticals Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Caliway Biopharmaceuticals Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Caliway Biopharmaceuticals Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliway Biopharmaceuticals Co Institutional Ownership Chart

Caliway Biopharmaceuticals Co Historical Data

The historical data trend for Caliway Biopharmaceuticals Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 8.72 9.20 9.56 9.72 10.04 10.10 10.23 10.38 8.87 8.91
TPE:6919
55GF Score
Caliway Biopharmaceuticals Co Ltd TPE:6919
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caliway Biopharmaceuticals Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.91% mean?
Caliway Biopharmaceuticals Co (TPE:6919) has a Institutional Ownership of 8.91% as of Aug. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Caliway Biopharmaceuticals Co and its competitors.
Is Caliway Biopharmaceuticals Co's Institutional Ownership too high?
Caliway Biopharmaceuticals Co's current Institutional Ownership is 8.91%. Overall, Caliway Biopharmaceuticals Co has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caliway Biopharmaceuticals Co's Institutional Ownership compare to VRTX and REGN?
Caliway Biopharmaceuticals Co's Institutional Ownership of 8.91% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Caliway Biopharmaceuticals Co and its competitors. Caliway Biopharmaceuticals Co's current Institutional Ownership is 8.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliway Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Caliway Biopharmaceuticals Co (TPE:6919) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$59.00, compared to a current price of NT$99.60 — trading 68.8% above its estimated fair value. The current Institutional Ownership is 8.91%. Caliway Biopharmaceuticals Co's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Caliway Biopharmaceuticals Co (TPE:6919), the current Institutional Ownership is 8.91% as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Caliway Biopharmaceuticals Co (TPE:6919) Overvalued in 2026?

Based on GuruFocus' analysis, Caliway Biopharmaceuticals Co stock appears to be overvalued. The current stock price of NT$99.60 is trading 68.8% above its estimated GF Value™ of NT$59.00. GuruFocus considers Caliway Biopharmaceuticals Co to be Significantly Overvalued.

Key valuation signals for TPE:6919:

  • Institutional Ownership: 8.91%
  • GF Value™: NT$59.00 vs. price of NT$99.60 (68.8% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the TPE:6919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Caliway Biopharmaceuticals Co Business Description

Address No.99, Section 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. The group has one operating segment, which is Healthy Food, and others.
55GF Score

Get the complete analysis for TPE:6919

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$99.60
Price
NT$59.00
GF Value